Publicaciones en las que colabora con Josep Tabernero Caturla (16)

2020

  1. Enhancing global access to cancer medicines

    CA Cancer Journal for Clinicians, Vol. 70, Núm. 2, pp. 105-124

2019

  1. Corrigendum: Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors (Annals of Oncology (2012) 23 (897-902) (DOI: 10.1093/annonc/mdr348)

    Annals of Oncology

2018

  1. Corrigendum: Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: A proof-of-principle (Annals of Oncology (2014) 25 (1729–1735) DOI: 10.1093/annonc/mdu239)

    Annals of Oncology

  2. Extracellular HMGA1 promotes tumor invasion and metastasis in triple-negative breast cancer

    Clinical Cancer Research, Vol. 24, Núm. 24, pp. 6367-6382

  3. P95HER2–T cell bispecific antibody for breast cancer treatment

    Science Translational Medicine, Vol. 10, Núm. 461

2015

  1. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

    Nature Communications, Vol. 6

  2. Erratum: Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity (Scientific Reports)

    Scientific Reports

  3. Patterns of HER2 gene amplification and response to anti-HER2 therapies

    PLoS ONE, Vol. 10, Núm. 6

2014

  1. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: A proof-of-principle

    Annals of Oncology, Vol. 25, Núm. 9, pp. 1729-1735

  2. Genomic aberrations in the FGFR pathway: Opportunities for targeted therapies in solid tumors

    Annals of Oncology, Vol. 25, Núm. 3, pp. 552-563

  3. Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer

    Journal of the National Cancer Institute, Vol. 106, Núm. 8

2013

  1. Circulating tumour cells and cell-free DNA as tools for managing breast cancer

    Nature Reviews Clinical Oncology, Vol. 10, Núm. 7, pp. 377-389

  2. Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity

    Scientific Reports, Vol. 3

2012

  1. Circulating tumour cells in early breast cancer

    The Lancet Oncology

  2. Trastuzumab-related cardiotoxicity in the elderly: A role for cardiovascular risk factors

    Annals of Oncology, Vol. 23, Núm. 4, pp. 897-902

2007

  1. Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors

    Endocrine-Related Cancer, Vol. 14, Núm. 2, pp. 221-232